Phosphorylation of β-catenin results in lack of β-catenin signaling in melanoma

International Journal of Oncology

Volumn 39, Issue 1, 2011, Pages 235-243

  Kuphal, Silke ^a   Bosserhoff, Anja Katrin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Melanoma; Phosphorylated hypophosphorylated catenin

Indexed keywords

BETA CATENIN; LITHIUM CHLORIDE; NERVE CELL ADHESION MOLECULE; SERINE; THREONINE;

ARTICLE; CELL LINE; COLON CARCINOMA; CYTOPLASM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

BETA CATENIN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SPACE; MELANOMA; PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 79956010370     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1028     Document Type: Article

References (40)

1. Kemler R: From Cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-321, 1993.
2. Kolligs FT, Bommer G and Goke B: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66: 131-144, 2002. (Pubitemid 36091845)
3. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
4. Wharton KA Jr: Runnin' with the Dv1: proteins that associate with Dsh/Dv1 and their significance to Wnt signal transduction. Dev Biol 253: 1-17, 2003.
5. Mao J, Wang J, Liu B, Pan W, Farr GH, III, Flynn C, Yuan H, Takada S, Kimelman D, Li L and Wu D: Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809, 2001. (Pubitemid 32436440)
6. Staal FJ, Noort MM, Strous GJ and Clevers HC: Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 3: 63-68, 2002. (Pubitemid 34144817)
7. 2+ signaling by Wnt-5A. Dev Biol 182: 114-120, 1997. (Pubitemid 27107320)
8. Weeraratna AT: A Wnt-er wonderland - the complexity of Wnt signaling in melanoma. Cancer Metastasis Rev 24: 237-250, 2005.
9. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray R Bittner M and Trent JM: Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288, 2002. (Pubitemid 41039152)
10. Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AR Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW and Haber DA: An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315: 642-645, 2007. (Pubitemid 46214707)
11. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F Briner J and von Knebel DM: Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59: 3880-3882, 1999. (Pubitemid 29393544)
12. Laken SJ, Papadopoulos N, Petersen GM, Gruber SB, Hamilton SR, Giardiello FM, Brensinger JD, Vogelstein B and Kinzler KW: Analysis of masked mutations in familial adenomatous polyposis. Proc Natl Acad Sci USA 96: 2322-2326, 1999. (Pubitemid 29117913)
13. Fukushima H, Yamamoto H, Itoh F, Horiuchi S, Min Y, Iku S and Imai K: Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability. J Exp Clin Cancer Res 20: 553-559, 2001. (Pubitemid 34087489)
14. Rimm DL, Caca K, Hu G, Harrison FB and Fearon ER: Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154: 325-329, 1999.
15. Reifenberger J, Knobbe CB, Wolter M, Blaschke B, Schulte KW, Pietsch T, Ruzicka T and Reifenberger G: Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. Int J Cancer 100: 549-556, 2002. (Pubitemid 34816155)
16. Worm J, Christensen C, Gronbaek K, Tulchinsky E and Guldberg P: Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 23: 5215-5226, 2004. (Pubitemid 38980354)
17. Larue L and Delmas V: The WNT/Beta-catenin pathway in melanoma. Front Biosci 11: 733-742, 2006.
18. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL and Moon RT: Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 106: 1193-1198, 2009.
19. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB and Akslen LA: Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 11: 8606-8614, 2005. (Pubitemid 43005907)
20. Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T and Ono T: Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 145: 210-216, 2001. (Pubitemid 32955344)
21. Maelandsmo GM, Holm R, Nesland JM, Fodstad O and Florenes VA: Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res 9: 3383-3388, 2003. (Pubitemid 37082733)
22. Kuphal S, Poser I, Jobin C, Hellerbrand C and Bosserhoff AK: Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 23: 8509-8519, 2004. (Pubitemid 39540801)
23. Kuphal S and Bosserhoff AK: Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene 25: 248-259, 2006. (Pubitemid 43083686)
24. Denk AE, Bettstetter M, Wild PJ, Hoek K, Bataille F, Dietmaier W and Bosserhoff AK: Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res 20: 112-119, 2007. (Pubitemid 46439520)
25. Halaban R Krauthammer M, Pelizzola M, Cheng E, Kovacs D, Sznol M, Ariyan S, Narayan D, Bacchiocchi A, Molinaro A, Kluger Y, Deng M, Tran N, Zhang W, Picardo M and Enghild JJ: Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. PLoS One 4: e4563, 2009.
26. Provost E, Yamamoto Y, Lizardi I, Stern J, D'Aquila TG, Gaynor RB and Rimm DL: Functional correlates of mutations in beta-catenin exon 3 phosphorylation sites. J Biol Chem 278: 31781-31789, 2003. (Pubitemid 37048359)
27. Rothhammer T, Bataille F, Spruss T, Eissner G and Bosserhoff AK: Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26: 4158-4170, 2007. (Pubitemid 46920167)
28. Rubinfeld B, Robbins P, El Gamil M, Albert I, Porfiri E and Polakis P: Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275: 1790-1792, 1997. (Pubitemid 27136716)
29. Rubinfeld B, Albert I, Porfiri E, Munemitsu S and Polakis P: Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 57: 4624-4630, 1997. (Pubitemid 27441070)
30. Pecina-Slaus N, Zigmund M, Kusec V, Martic TN, Cacic M and Slaus M: E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis. J Cutan Pathol 34: 239-246, 2007. (Pubitemid 46239313)
31. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X and He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847, 2002. (Pubitemid 34327534)
32. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben Shushan E, Mann M, Ben Neriah Y and Alkalay I: Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 16: 1066-1076, 2002. (Pubitemid 34507196)
33. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ and Harper JW: The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13: 270-283, 1999. (Pubitemid 29095799)
34. Hart M, Concordet JP, Lassot I, Albert I, del los SR, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R and Polakis P: The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9: 207-210, 1999. (Pubitemid 29120385)
35. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
36. Spink KE, Polakis P and Weis WI: Structural basis of the Axin-adenomatous polyposis coli interaction. EMBO J 19: 2270-2279, 2000. (Pubitemid 30259008)
37. Kielhorn E, Provost E, Olsen D, D'Aquila TG, Smith BL, Camp RL and Rimm DL: Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer 103: 652-656, 2003. (Pubitemid 36091470)
38. Birchmeier C, Birchmeier W and Brand-Saberi B: Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 156: 217-226, 1996. (Pubitemid 27072577)
39. Kim K, Daniels KJ and Hay ED: Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness. Exp Cell Res 245: 79-90, 1998. (Pubitemid 28551057)
40. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM and Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120: 757-766, 1993. (Pubitemid 23035144)